Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.76 EUR | -11.52% | -14.96% | -13.10% |
12:01pm | Nanobiotix: strategy update, share price declines | CF |
May. 21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.10% | 333M | |
+58.48% | 55.07B | |
-1.90% | 41.79B | |
+44.59% | 40.22B | |
-8.29% | 28.17B | |
+12.11% | 26.28B | |
-20.89% | 18.93B | |
+6.87% | 13.03B | |
+28.77% | 12.26B | |
+26.35% | 12.21B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix Prices $55 Million Share Sale in US, Europe; Paris Stock Closes Lower